FDA Issues First Guidance on Clinical Trials for Psychedelic Drugs
Cannabis Law Report
JUNE 30, 2023
Food and Drug Administration (FDA or Agency) on June 23, 2023, released its first draft guidance concerning design and desired features of clinical trials for psychedelic drugs LSD and MDMA There has been growing interest in studying the use of psychedelic drugs for […]
Let's personalize your content